Transcriptome analysis of the ependymal barrier during murine neurocysticercosis
© Mishra and Teale; licensee BioMed Central Ltd. 2012
Received: 15 January 2012
Accepted: 23 May 2012
Published: 25 June 2012
Central nervous system (CNS) barriers play a pivotal role in the protection and homeostasis of the CNS by enabling the exchange of metabolites while restricting the entry of xenobiotics, blood cells and blood-borne macromolecules. While the blood–brain barrier and blood-cerebrospinal fluid barrier (CSF) control the interface between the blood and CNS, the ependyma acts as a barrier between the CSF and parenchyma, and regulates hydrocephalic pressure and metabolic toxicity. Neurocysticercosis (NCC) is an infection of the CNS caused by the metacestode (larva) of Taenia solium and a major cause of acquired epilepsy worldwide. The common clinical manifestations of NCC are seizures, hydrocephalus and symptoms due to increased intracranial pressure. The majority of the associated pathogenesis is attributed to the immune response against the parasite. The properties of the CNS barriers, including the ependyma, are affected during infection, resulting in disrupted homeostasis and infiltration of leukocytes, which correlates with the pathology and disease symptoms of NCC patients.
In order to characterize the role of the ependymal barrier in the immunopathogenesis of NCC, we isolated ependymal cells using laser capture microdissection from mice infected or mock-infected with the closely related parasite Mesocestoides corti, and analyzed the genes that were differentially expressed using microarray analysis. The expression of 382 genes was altered. Immune response-related genes were verified by real-time RT-PCR. Ingenuity Pathway Analysis (IPA) software was used to analyze the biological significance of the differentially expressed genes, and revealed that genes known to participate in innate immune responses, antigen presentation and leukocyte infiltration were affected along with the genes involved in carbohydrate, lipid and small molecule biochemistry. Further, MHC class II molecules and chemokines, including CCL12, were found to be upregulated at the protein level using immunofluorescence microcopy. This is important, because these molecules are members of the most significant pathways by IPA analyses.
Thus, our study indicates that ependymal cells actively express immune mediators and likely contribute to the observed immunopathogenesis during infection. Of particular interest is the major upregulation of antigen presentation pathway-related genes and chemokines/cytokines. This could explain how the ependyma is a prominent source of leukocyte infiltration into ventricles through the disrupted ependymal lining by way of pial vessels present in the internal leptomeninges in murine NCC.
There are different central nervous system (CNS) barriers, which play a critical role in the homeostasis of the CNS . However, CNS infections lead to the dysfunction of these barriers. Compromised barrier properties result in leakage of blood-born cells and molecules, as well as a perturbed homeostasis of ions and macromolecules causing brain pathology . Neurocysticercosis (NCC) is a CNS infection caused by the metacestode larva(e) form of the parasite Taenia solium and is characterized by a range of pathological symptoms including epileptic seizures, headaches and hydrocephalus . Recently, using a murine model for NCC, we have reported that the distinct CNS barriers are differentially compromised during parasite infection [2–5].
The CNS barriers include the blood–brain barrier (BBB) comprised of pial and parenchymal vessels present in the leptomeninges and cortex, respectively, and the blood cerebrospinal fluid barrier (BCB) present in the choroid plexus [1, 6]. The BBB and BCB prevent circulating blood cells and macromolecules from getting into the CNS as well as selectively regulating the exchange of metabolites between blood and CSF. In addition to these barriers, the lining of the ventricles known as the ependymal layer functions as a third barrier separating the CSF from the CNS tissue/parenchyma .
The ependymal barrier is composed of a single layer of uniformly arranged ependymal cells or ependymocytes of epithelial nature [1, 7, 8]. The barrier properties of ependyma are evident from the presence of molecules known to contribute to intercellular communication, paracellular sealing and adherence of cells such as the gap junction molecule connexin-43 [9, 10], the tight junction molecules occludin and ZO-1, and adherens junction molecules such as cadherins, α-catenin and β-catenin [3, 11]. Ependymal barrier function is further supported by the presence of enzymes such as glutathione-S-transferase isoforms and monoamine oxidase (MAO), which are known to participate in the metabolism of neuroactive and vasoactive amines enabling the ependyma to act as an amine-barrier system [12–15]. In addition, the presence of electrolyte and water transporters such as aquaporin family member 4 (AQP4) participates in the maintenance of hydrocephalic pressure . The ependyma also appears to play a crucial role in the homeostasis of the CNS by exchanging toxic metabolic byproducts and water between the interstitial fluid of CNS cells and the CSF in ventricles. However, despite the known, critical barrier properties of the ependymal layer, the effect of infection on ependymal cells has been largely understudied.
Previously, we have reported the presence and induction of Toll-like receptors (TLRs) in the ependyma during murine NCC . We have also described leukocyte infiltration through the ependyma , indicating the compromised integrity of the ependymal barrier [3, 5, 17]. We hypothesize that the ependyma can be an immunologically active site that upon activation can produce immune effector molecules that support leukocyte transmigration and the dysfunction of the ependymal barrier. To test this hypothesis, we isolated ependymal cells using Laser Capture Microdissection (LCM) and applied a holistic approach of microarray analyses to analyze potential infection-induced changes in gene expression of the ependymal barrier. Results from the transcriptome analyses of the ependyma indicate that networks of genes related to the immune response, cellular function and maintenance are affected, which likely contribute to the neuropathology of NCC.
Materials and methods
Three- to 5-week-old female BALB/c mice were purchased from the National Cancer Institute program (Bethesda, MD). Experiments were conducted under the guidelines of the IACUC, University of Texas System, the US Department of Agriculture and the National Institutes of Health.
Parasites and infection
Parasite maintenance and intracranial infection were performed using our protocol developed earlier . M. corti metacestodes were maintained by serial intraperitoneal (i.p.) inoculation of 8- to 12-week-old female BALB/c mice. For intracranial inoculations, parasites were aseptically collected from the i.p. cavity of mice that had been infected for about 4–6 months. Harvested parasites were extensively washed in HBSS. Approximately 70 metacestodes were then suspended in 50 μl of HBSS and injected intracranially into 3- to 5-week-old female BALB/c mice using a 1-ml syringe and a 25-gauge needle . The needle was inserted to a 2-mm depth at the junction of the superior sagittal and the transverse sutures. This allows insertion of the needle into a protective cuff avoiding penetration of the brain tissue. Control mice were injected with 50 μl sterile HBSS using the same protocol. Before intracranial inoculation, mice were anesthetized intramuscularly with a 50-μl mixture of ketamine HCL and xylazine (30 mg/ml ketamine and 4 mg/ml xylazine).
Laser captured microdissection microscopy
Animals were killed 3 weeks after inoculation, which was the peak of inflammation . Before sacrifice, animals were anesthetized with 50 μl of a mixture of ketamine HCL and xylazine as above, and perfused through the left ventricle with 15 ml of cold PBS. Perfused brains were immediately removed, embedded in OCT resin (Sakura, Torrance, CA) and snap frozen in 2-methyl butane (Fisher Scientific, Pittsburgh, PA) contained in liquid nitrogen and stored at −80°C for later use. Then 10-μm-thick horizontal cryosections were serially cut from each brain and placed on polyethylene naphthalate membrane slides (Leica Microsystems, Wetzlar, Germany). The tissue sections were fixed in −20°C acetone for 20 s and kept in dry ice followed by rapid immunofluorescence staining. Briefly, tissues were subjected to 70% ethanol at −20°C for 3 min and washed with PBS. Sections were incubated with rabbit anti-mouse β catenin (Zymed, San Francisco, CA) primary antibody for 5 min followed by three washes for 1 min each. Rhodamine Red-X (RRX)-conjugated goat anti-rabbit secondary antibody (Jackson ImmunoResearch, West Grove, PA) was applied for 3 min to detect primary antibody followed by three washes. RNasin® RNase Inhibitor (Promega, Madison, WI) and DEPC water were used as required to ensure an RNase-free procedure. Then, sections were serially dehydrated in 70% (10 s), 95% (20 s), 100% (3× for 30 s each) and Shandon Histosolve™ Xylene Substitute, an isoalkene hydrocarbon-based solution (Shandon, Pittsburgh, PA) 2× for 2 min each. Dehydrated sections were kept under desiccation until use for LCM. Three animals per group (mock infection and M. corti infection) were used to isolate ependymal cells. LCM was performed with a Leica LMD 7000 micro systems (Leica Microsystems, Wetzlar Germany).
RNA isolation and linear amplification
From LCM-isolated ependymal cells, RNA was extracted with the Pico PureTM RNA isolation kit (Arcturus Bioscience, Mountain View, CA) according to manufacturer’s protocol. DNase (Qiagen, Valencia, CA) treatment was performed directly within the purification column to remove any possible genomic contamination during the RNA extraction process. The quality of the RNA was inspected with the Agilent 2100 Bioanalzyer and NanoDrop ND-1000. Samples passing quality control assessment were then subjected to linear amplification and subsequently labeled with the NuGEN Ovation Aminoallyl RNA Amplification and Labeling System (NuGEN Technologies, San Carlos, CA) as per manufacturer’s instructions.
Microarray and data processing
Arrays were printed at the Duke Microarray Facility using the Genomics Solutions OmniGrid 100 Arrayer and mouse genome oligo set (version 4.0). The Mus musculus Operon v4.0 spotted microarray contains 35,852 longmer probes representing 25,000 genes and about 38,000 gene transcripts (Operon Biotechnologies, Huntsville, AL). The amplified and labeled product was hybridized to Mus musculus Operon v4.0 spotted microarray according to the manufacturer’s protocol at 42°C with the MAUI hybridization system (BioMicro Systems, MAUI hybridization System, Salt Lake City, UT). The array was then washed at increasing stringencies and scanned on a GenePix 4000B microarray scanner (Axon Instruments, Foster City, CA). Data processing and statistical analysis with the software Genespring 7.3 (Agilent Technologies, Redwood City, CA) were used to perform data analysis. Intensity-dependent (Lowess) normalization was done on the entire data set. To assess the quality of the data set, a principle component analysis was performed on samples on expression of all genes with mean centering and scaling. Data sets were filtered based on values, and probe sets with background-subtracted intensity of 44 or less were excluded from the analysis. Based on replicates of each condition, pair-wise comparisons were performed on data set samples from mock-infected vs. infected samples. Differentially expressed probe sets were selected based on a volcano plot with a two-fold change and a p-value cutoff of 0.05. Differentially expressed genes were then clustered using Average Linkage with Pearson correlation as the similarity measurement. Molecular networks of the selected molecules and specific pathways were analyzed with Ingenuity Pathway Analysis (IPA) software (Agilent Technologies).
Real-time RT-PCR analysis
RNA obtained from LCM-isolated ependymal cells was subjected to linear amplification by the WT-Ovation™ Pico System (Nugen Technology). The resulting cDNA was loaded onto Taq-Man Low Density Arrays microfluidic cards, catalog number −4342259 (Applied Biosystems, Carlsbad, CA) preloaded with fluorogenic probes and custom-designed primers for genes of interest and the housekeeping genes β-actin, ribosomal 18 S and GAPDH (glyceraldehyde 3-phosphate dehydrogenase) . In some experiments, the commercially available Mouse Immune Array, catalog number 4367786 (Applied Biosystems) was used. The plates were then loaded on an ABI Prism 7900 HT Sequence Detection System (Applied Biosystems). The target expression levels were normalized to levels of the housekeeping genes 18 S, β-actin and GAPDH in the same sample. In addition, real-time RT-PCR to assess the relative expression of CCL12 and CCL7 chemokines in infected samples over mock-infected samples was performed using Sybr Green (Applied Biosystems, CA). Primers for CCL12, CCL7 and 18 S were generated using Primer Express software (Applied Biosystems) as follows: 18 S, forward: CGG-CTA-CCA-CAT-CCA-AGG-AA, reverse: GCT-GGA-ATT-ACC-GCG-GCT; CCL-12, forward: TGC-CTC-CTG-CTC-ATA-GCT-ACC, reverse: ACT-GGC-TGC-TTG-TGA-TTC-TCC; CCL7, forward: GGA-TCT-CTG-CCA-CGC-TTC-TG, reverse: GGC-CCA-CAC-TTG-GAT-GCT. Expression of each specific gene in infected samples over mock was calculated by the 2-ΔΔCt method, and results are represented as ΔΔCt over mock .
Tissue preparation and immunofluorescence microscopy
Tissue preparation and immunofluorescence (IF) staining were performed using our protocol as described previously . Mock-infected and infected brains were harvested as described above. Perfused brains were immediately removed, embedded in OCT resin (Sakura, Torrance, CA) and stored at −80°C. Serial horizontal 10-μm-thick cryosections were placed on Silane-prep slides (Sigma-Aldrich, St. Louis, MO). The slides were air dried overnight and fixed in fresh acetone for 20 s at RT. Acetone-fixed sections were wrapped in aluminum foil and stored at −80°C or processed immediately for IF staining. Briefly, tissues were fixed in −20°C acetone for 10 min and then hydrated in PBS. Non-specific immunoglobulin binding was blocked by 30-min incubation at RT with 10% serum from the same species that the fluorochrome-conjugated antibodies were derived. Sections were incubated for 40 min with primary antibodies diluted in 3% species-specific serum. Sections were washed 7× for 3 min each after incubation with the specified antibodies. Secondary antibodies were incubated for 30 min at RT when necessary. Then, sections were mounted using Fluorsave reagent (Calbiochem, La Jolla, CA) containing 0.3 μM 4′,6′-diamidino-2-phenylindole dilactate (DAPI; Molecular Probes, Eugene, OR). Negative controls using secondary antibodies alone were included in each experiment and found to be negative for staining. Fluorescence was visualized in a Leica microscope (Leica Microsystems, Wetzlar Germany). Images were acquired and processed using IP lab software and Adobe Photoshop CS2 (Adobe, Mountain View, CA). The primary antibodies against CCL12 (catalog n–o. BAF428) and CCL5 (catalog no. AF478) were bought from R&D systems (Minneapolis, MN). Biotinylated MHC II A/D antibody (catalog n–o. 553622) was purchased from BD Pharmingen™ (San Diego, CA). Secondary antibody rabbit anti-goat conjugated with RRX was obtained from Jackson ImmunoResearch (West Grove, MD) and Streptavidin-RRX from Molecular Probes (Invitrogen, CA).
Ependymal cell isolation
Assessment of differentially expressed genes in the ependyma resulting from infection
Operon chips represent the whole transcriptome derived from the mouse genome depicting both well-characterized genes and uncharacterized genes (Expression Sequence Tags). To identify the genes represented by differentially expressed probe sets, the data generated by Genespring were uploaded into Ingenuity Pathway Analysis software (IPA). Out of 563 probe sets, 400 probes were found annotated and represent 382 genes. Among 382 genes identified based on the common annotation “Ref. Seq,” 301 were upregulated and 81 were downregulated.
List of the most up- and downregulated (−) genes in ependymal cells from M. corti-infected brain in comparison to mock-infected brain samples
Arginine and proline metabolism; urea cycle and metabolism of amino groups
MHC class II protein binding
Antigen processing and presentation of exogenous peptide antigen via MHC class II
Chemokine activity; heparin binding
Cell-cell signaling; chemotaxis
G-protein coupled receptor binding
Acute-phase response; chemotaxis
Antigen processing and presentation; aprotein polyubiquitination
Beta-2-microglobulin binding; MHC class I receptor activity
Antigen processing and presentation of peptide antigen via MHC class I
Collagen binding; protein binding
Apoptotic process; biomineral tissue development; blood coagulation; maintenance of granzyme B location in T cell secretory granule
MHC class I receptor activity
Antigen processing and presentation of peptide antigen via MHC class I
MHC class I receptor activity
Antigen processing and presentation of peptide antigen via MHC class I
Complement component C3a receptor activity; G-protein coupled receptor activity;
Chemotaxis; complement receptor-mediated signaling pathway
Regulation of transcription
Sequence-specific DNA binding transcription factor activity
Cell fate commitment; cilium assembly; epithelial cell development
Regulation of centriole replication
Actin binding; calcium- dependent ATPase activity
Muscle contraction; muscle filament sliding; regulation of ATPase activity
I-kappaB kinase/NF-kappaB cascade
Methyltransferase activity; transferase activity
RNA 3'-end processing
Termination of RNA polymerase II transcription
Lipid biosynthetic process; steroid biosynthetic process; transport
Negative regulation of nuclear mRNA splicing, regulation of transcription
Biofunctions and networks of differentially expressed genes
Top biological functions associated with genes differentially expressed in ependymal cells from NCC brain
Diseases and disorders
9.03E-19 - 1.61E-03
2.87E-13 - 1.37E-03
1.25E-11 - 9.66E-04
1.84E-11 - 9.10E-04
Connective tissue disorders
2.15E-10 - 7.88E-04
Molecular and cellular functions
4.49E-14 - 1.61E-03
5.98E-12 - 1.32E-03
Cellular growth and proliferation
2.37E-11 - 1.61E-03
Cell-to-cell signaling and interaction
1.36E-10 - 1.61E-03
2.87E-09 - 1.58E-03
Physiological system development and function
Hematological system development and function
1.29E-11 - 1.61E-03
Immune cell trafficking
1.29E-11 - 1.61E-03
9.56E-11 - 1.45E-03
4.10E-10 - 1.56E-03
Cell-mediated immune response
3.05E-08 - 1.27E-03
Verification of infection-induced gene expression in the ependyma by real-time PCR
ΔΔ Ct value
Genes mentioned in bold red color represent upregulated genes, and genes in bold green color represent downregulated genes. Genes in black color are not affected in the data set but are relevant to the networks. (Description and fold change associated with differentially affected genes are described in Additional file 1: Table S1).
Gene expression analysis by real-time PCR using the cDNA linearly amplified from LCM-isolated ependymal cells from mock-infected and infected brain samples. Results are expressed as a ΔΔCt over mock-infected control mice and compared with the microarray outcome
Verification of infection-induced changes in immune-related gene expression in ependyma
To confirm the altered pattern of gene expression obtained from the microarray analysis, Taqman RT-PCR was performed with amplified cDNA from LCM-isolated ependymal cell RNA for a number of genes (Table 3). Genes were chosen based on the outcome of the network and pathway analysis and with emphasis on the immune response (Figure 3 and Additional file 3: Table S3). All of the genes analyzed were confirmed to be significantly upregulated by RT-PCR and included antigen presentation-related genes β2 microglobulin, MHC II and transcription factor STAT1. Among the chemokines, CCL2, CCL12, CXCL10 and CXCLl1 were upregulated and relevant for trafficking of monocytes and T cells, two leukocyte subsets that are known to traffic through the ependyma during NCC . In addition, CCL5 and CCL7 were shown to be upregulated by RT-PCR (CCL5, 15.5 fold, SE 0.64; CCL7, 8.7 fold, SE 0.74).
Protein expression of MHC class II and chemokine expression by the ependyma
Disruption of the barrier properties of CNS barriers correlates highly with brain pathology [1, 28]. In healthy individuals the BBB is controlled in part by endothelial cells that prevent blood cells and blood-borne molecules from entering into the CNS as well as regulating exchange of metabolites. The BCB, which is comprised of the choroid plexuses consisting of modified epithelial cells surrounding fenestrated blood vessels, is a site of CSF production and helps to regulate the exchange of metabolites and provide immune surveillance . During CNS infections, the BBB acts as a route for leukocyte infiltration from blood to the subarachnoid space and parenchyma, while the BCB has been described as a route of leukocyte infiltration from blood to the CSF . However, our prior studies demonstrate that during murine NCC, another route for leukocyte infiltration from blood to ventricles is through a disrupted ependymal layer by way of subependymal pial vessels present in the internal leptomeninges [2, 3, 5]. Such ependymal disruption correlates with infection-induced increases in MMP8, 3, 12, 2, 9 and 16 in addition to dislocated/rearranged patterns of ependymal junction proteins including occludin, cadherin, catenin α and β [2, 3, 5]. The ependymal layer consists of specialized epithelial cells that separate the parenchyma and the CSF, and regulate hydrocephalic pressure and metabolic toxicity [7, 8]. Of the few studies of the ependyma, most have focused on the transporters or physiological functions of ependyma . Recently, our laboratory and others have shown disease-related induction in ependymal cells of TLR2, 4, 6 and 7 [17, 31, 32] as well as IL1R  and IL18 , suggesting that the ependyma contributes to the inflammatory process. It is particularly relevant for NCC since in many clinical cases, as well as in the murine NCC model, parasites can be lodged in ventricles, providing direct access of antigen/PAMPs to ependymal cells [2, 35]. The aim of this study was to assess broad-based changes as well as immune-related changes in gene expression of ependymal cells, leading to compromised barrier function and leukocyte infiltration as a result of parasite infection. To date, no comprehensive study has been done with the ependyma, mainly because of the difficulty in isolating ependymal cells.
With the advent of LCM, it is possible to isolate a homogeneous cell population from heterogeneous tissue and monitor such changes. In brain, the ependyma lies between the parenchyma and internal leptomeninges separated by a basement membrane . As mentioned above, optimized dehydration with an isoalkene hydrocarbon-based solution that acts as a substitute for xylene caused the ependymal layer to dissociate from closely associated brain parenchyma and meninges, reducing contamination from other cells (Figure 1). Further, genes highlighted in networks involved in the metabolism and cellular growth as well as in metabolic pathways have been described previously in the ependyma, such as induced expression of IGF1 , VIP , glucokinase , ferric-chelate reductase 1 molecules  and adenosine deaminase . In addition, several transporters are affected during infection, which might provide insight into a perturbed homeostasis during NCC because of ependymal cell activation, for example, a reduced expression of the aquaporin family member AQP11. Studies using AQP11-deficient mice have shown an abnormal swelling of epithelial cells in kidneys, leading to cyst formation in proximal tubes and eventually renal failure and death . Similarly, expression of fatty acid-binding protein FABP7, which binds to polyunsaturated fatty acid, correlates with neuroepithelial cell differentiation  and ATP1B1, which ensures a proper electrochemical gradient across the plasma membrane, are reduced, among others. In contrast, the expression of the transporter molecule ATP-binding cassette family member, multiple drug resistance protein 3 (ABCC3) is upregulated. ABCC3 is known to be induced as a result of immune activation by the oncostatin-mediated pathway (OSM) .
Broad classification of differentially expressed genes in gene networks and related biofunctions indicates that genes involved in antigen recognition, uptake, processing, presentation and immune effector functions are induced. Metacestodes during NCC continuously secrete antigens, particularly glycoconjugates, some of which act as PAMPS [41–46]. The murine NCC model developed in our laboratory using a closely related cestode also shows a similar release pattern of antigenic glycoconjugates. Immune responses vary depending upon the location of metacestodes in the CNS. Metacestodes lodged in ventricles and subarachnoid spaces are known to cause more inflammation, symptoms related with hydrocephalic pressure and associated epileptic seizures [2, 35, 47]. In a previous study, we showed that parasite-derived antigens are detected in the ventricles and ependymal layer using a monoclonal antibody against a secreted M. corti antigen . Possible recognition and phagocytosis are apparent by the induction of pathways such as Fc receptor-mediated phagocytosis and complement.
One of the striking observations is the upregulation of MHC class I and class II genes in ependyma at both the gene expression and protein level. MHC II antigen expression has been detected in non-professional antigen-presenting cells of other immune privileged sites such as the conjunctival epithelium in trachoma . In CNS ventricles, choroid plexus epithelial cells have been shown to have increased expression of MHC I and MHC II antigens upon infection with Theiler’s murine encephalomyelitis virus (TMEV) and spontaneous canine distemper virus encephalitis [49, 50]. Further, upon stimulation with IFNγ under in vitro conditions, choroid plexus epithelial cells have been shown to express MHC class II molecules and present antigen to T cells . During murine NCC, we have observed the presence of αβ-T cells at 3 weeks p.i. in ventricles . It is possible that antigen availability and the activation state of ependyma influence the trafficking and/or expansion/skewing of T cells in the ventricles. In addition, it might also help in the retention of T cells in ventricles that have migrated through the activated ependyma, as recent reports suggest that antigen presentation upon egress from the BBB helps T cells to stay in the CNS environment .
There are several potential mechanisms leading to ependymal cell activation and MHC upregulation evident in the array data. One such gene, STAT1, was verified by RT-PCR , which has been shown to regulate the antigen presentation pathway along with IRF1 . Induction of transcription factors STAT1, IRF1, IRF5 and 7 also correlates with our previous finding in which the ependyma was found to express high levels of TLR7 during infection  and is in agreement with the study in which IFNγ administration in rats by intravenous infusion led to induction of MHC class II in various cells including the ependyma . Other reports have shown that IFNγ stimulation leads to induction of MHC II in bronchial epithelial cells, and upon engagement with bacterial superantigen, toxic shock syndrome toxin 1 (TSST1) mediates TNFα and IL8 gene expression [56–59].
Our data show that during infection, ependymal cell activation leads to expression of chemokines. Chemokines play a critical role in leukocyte infiltration. Chemokines exert chemotaxis by binding to their respective receptor that leads to downstream signaling events resulting in the tight binding of leukocytes . Our data show that chemokines CCL2, CCL5, CCL7, CCL8, CCL9, CCL6, CCL12, CCL11, CCL13, CXCL10 and CXCL11 are upregulated by infection at the transcript level. Our experiments further indicate the protein localization pattern of CCL12 and CCL5 in apical and baso-lateral surfaces of ependymal cells. Among these chemokines, monocyte chemoattractant protein (MCP) family members CCL2, CCL8, CCL12 and CCL13 are known ligands for CCR2 expressed by monocytes . Studies in the Experimental Autoimmune Encephalitis (EAE) model using CCR2 −/− mice indicate that CCR2 plays a crucial role in recruitment of monocytes, and these mice are resistant to EAE . Among the ligands for CCR2, CCL2 has been shown to be non-redundant as mice lacking CCL2 display a similar clinical phenotype as the CCR2 −/− mice during EAE and are characterized by impaired monocyte recruitment . In addition, CXCL10 and CXCL11 chemokines are recognized by chemokine receptor CXCR3, which is expressed by activated T cells [62, 63]. Blockade of CXCL10 with neutralizing antibodies results in reduced numbers of inflammatory T cells and decreased severity of EAE. Similarly, neutralization of CXCR3 reduces CD4+ T cell infiltration into the CNS upon intracranial infection with the mouse hepatitis virus (MHV) and mitigates demyelination . CXCR3 has been thought to play a role in retention of CD4+ T cells in CNS . Expression of these chemokines by ependymal cells likely attracts leukocytes expressing respective receptors and enhances trafficking of leukocytes into the ventricles originating from pial vessels in the internal leptomeninges.
Taken together, our data suggest that gene expression by ependymal cells is dramatically affected by parasite infection in murine NCC. Although some contamination by extravasating leukocytes present in the ependymal layer cannot be ruled out, it appears to be minimal based on no change in the expression of lymphoid markers such as CD4, CD8 and CD19 as well as myeloid cell markers such as CD11b, CD11c and Ly6G between mock-infected and infected mice. Importantly, the data indicate that the ependyma becomes an immunologically active site. Thus, it appears that the ependyma contributes to the immunopathology associated with NCC and consistent with the ventriculitis associated with this disease [65, 66].
This study provides the first comprehensive gene expression analysis of ependymal cells in a disease condition. Our microarray results derived from ependymal cells establish the biomarkers affected in the ependyma barrier during parasitic infection. Specific pathways indicate that ependymal cells actively express immune mediators and likely contribute to the observed immunopathogenesis during NCC [65–70]. In addition, during CNS infections, the BBB and BCB are described as the main routes of leukocyte infiltration . However, during murine NCC, the ependyma is a prominent source of leukocyte infiltration into the ventricles (blood to the ventricle) . To this end, upregulation of antigen presentation pathway-related genes and chemokines/cytokines are important and provide insight into how ependymal cells could support leukocyte infiltration.
This research was supported by award NS 35974 from the National Institutes of Health to JT. We want to thank Computational Biology Initiative, University of Texas at San Antonio, for providing access to IPA software and Ms. Zhengzheng Wei from Duke Microarray Facility, Duke University Medical Center, for help with the microarray experiment.
- Saunders NR, et al: Barriers in the brain: a renaissance?. Trends Neurosci. 2008, 31 (6): 279-286. 10.1016/j.tins.2008.03.003.View ArticlePubMed
- Alvarez JI, et al: Mesocestoides corti intracranial infection as a murine model for neurocysticercosis. Parasitology. 2010, 137 (3): 359-372. 10.1017/S0031182009991971.View ArticlePubMed
- Alvarez JI, Teale JM: Differential changes in junctional complex proteins suggest the ependymal lining as the main source of leukocyte infiltration into ventricles in murine neurocysticercosis. J Neuroimmunol. 2007, 187 (1–2): 102-113.PubMed CentralView ArticlePubMed
- Alvarez JI, Teale JM: Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature. Brain Res. 2007, 1169: 98-111.PubMed CentralView ArticlePubMed
- Alvarez JI, Teale JM: Multiple expression of matrix metalloproteinases in murine neurocysticercosis: implications for leukocyte migration through multiple central nervous system barriers. Brain Res. 2008, 1214: 145-158.PubMed CentralView ArticlePubMed
- Ransohoff RM, Kivisakk P, Kidd G: Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol. 2003, 3 (7): 569-581. 10.1038/nri1130.View ArticlePubMed
- Del Bigio MR: The ependyma: a protective barrier between brain and cerebrospinal fluid. Glia. 1995, 14 (1): 1-13. 10.1002/glia.440140102.View ArticlePubMed
- Bruni JE: Ependymal development, proliferation, and functions: a review. Microsc Res Tech. 1998, 41 (1): 2-13. 10.1002/(SICI)1097-0029(19980401)41:1<2::AID-JEMT2>3.0.CO;2-Z.View ArticlePubMed
- Yamamoto T, et al: Differential anatomical and cellular patterns of connexin43 expression during postnatal development of rat brain. Brain Res Dev Brain Res. 1992, 66 (2): 165-180.View ArticlePubMed
- Jarvis CR, Andrew RD: Correlated electrophysiology and morphology of the ependyma in rat hypothalamus. J Neurosci. 1988, 8 (10): 3691-3702.PubMed
- Lippoldt A, et al: Phorbol ester induced changes in tight and adherens junctions in the choroid plexus epithelium and in the ependyma. Brain Res. 2000, 854 (1–2): 197-206.View ArticlePubMed
- Abramovitz M, et al: Characterization and localization of glutathione-S-transferases in rat brain and binding of hormones, neurotransmitters, and drugs. J Neurochem. 1988, 50 (1): 50-57. 10.1111/j.1471-4159.1988.tb13228.x.View ArticlePubMed
- Carder PJ, et al: Glutathione S-transferase in human brain. Neuropathol Appl Neurobiol. 1990, 16 (4): 293-303. 10.1111/j.1365-2990.1990.tb01264.x.View ArticlePubMed
- Saura J, Richards JG, Mahy N: Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs. Neurobiol Aging. 1994, 15 (4): 399-408. 10.1016/0197-4580(94)90071-X.View ArticlePubMed
- Williams D, et al: Histochemical characterization of monoamine oxidase in ependyma of rat hypothalamus. Histochem J. 1979, 11 (1): 83-95. 10.1007/BF01041267.View ArticlePubMed
- Jung JS, et al: Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance. Proc Natl Acad Sci USA. 1994, 91 (26): 13052-13056. 10.1073/pnas.91.26.13052.PubMed CentralView ArticlePubMed
- Mishra BB, Mishra PK, Teale JM: Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J Neuroimmunol. 2006, 181 (1–2): 46-56.PubMed CentralView ArticlePubMed
- Cardona AE, et al: Development of an animal model for neurocysticercosis: immune response in the central nervous system is characterized by a predominance of gamma delta T cells. J Immunol. 1999, 162 (2): 995-1002.PubMed
- Mishra BB, Gundra UM, Teale JM: STAT6/mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis. J Neuroimmunol. 2011, 232 (1–2): 26-34.PubMed CentralView ArticlePubMed
- Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.View ArticlePubMed
- Alvarez JI, Teale JM: Breakdown of the blood brain barrier and blood-cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC. J Neuroimmunol. 2006, 173 (1–2): 45-55.View ArticlePubMed
- Toyama-Sorimachi N, et al: Widespread expression of chondroitin sulfate-type serglycins with CD44 binding ability in hematopoietic cells. J Biol Chem. 1997, 272 (42): 26714-26719. 10.1074/jbc.272.42.26714.View ArticlePubMed
- Wang S, et al: Loss of Myt1 function partially compromises endocrine islet cell differentiation and pancreatic physiological function in the mouse. Mech Dev. 2007, 124 (11–12): 898-910.PubMed CentralView ArticlePubMed
- Vanhorenbeeck V, et al: Role of the Onecut transcription factors in pancreas morphogenesis and in pancreatic and enteric endocrine differentiation. Dev Biol. 2007, 305 (2): 685-694. 10.1016/j.ydbio.2007.02.027.View ArticlePubMed
- Margagliotti S, et al: The Onecut transcription factors HNF-6/OC-1 and OC-2 regulate early liver expansion by controlling hepatoblast migration. Dev Biol. 2007, 311 (2): 579-589. 10.1016/j.ydbio.2007.09.013.View ArticlePubMed
- Zhou Y, et al: The mammalian Golgi regulates numb signaling in asymmetric cell division by releasing ACBD3 during mitosis. Cell. 2007, 129 (1): 163-178. 10.1016/j.cell.2007.02.037.View ArticlePubMed
- Tsang WY, et al: Cep76, a centrosomal protein that specifically restrains centriole reduplication. Dev Cell. 2009, 16 (5): 649-660. 10.1016/j.devcel.2009.03.004.PubMed CentralView ArticlePubMed
- Hawkins BT, Egleton RD: Pathophysiology of the blood–brain barrier: animal models and methods. Curr Top Dev Biol. 2008, 80: 277-309.View ArticlePubMed
- Engelhardt B, Sorokin L: The blood–brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol. 2009, 31 (4): 497-511. 10.1007/s00281-009-0177-0.View ArticlePubMed
- Del Bigio MR: Ependymal cells: biology and pathology. Acta Neuropathol. 2010, 119 (1): 55-73. 10.1007/s00401-009-0624-y.View ArticlePubMed
- Letiembre M, et al: Innate immune receptor expression in normal brain aging. Neuroscience. 2007, 146 (1): 248-254. 10.1016/j.neuroscience.2007.01.004.View ArticlePubMed
- Xia Y, Yamagata K, Krukoff TL: Differential expression of the CD14/TLR4 complex and inflammatory signaling molecules following i.c.v. administration of LPS. Brain Res. 2006, 1095 (1): 85-95. 10.1016/j.brainres.2006.03.112.View ArticlePubMed
- French RA, et al: Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice. J Neuroimmunol. 1999, 93 (1–2): 194-202.View ArticlePubMed
- Sugama S, et al: Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS. Brain Res. 2002, 958 (1): 1-9. 10.1016/S0006-8993(02)03363-2.View ArticlePubMed
- Garcia HH, Del Brutto OH: Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 2005, 4 (10): 653-661. 10.1016/S1474-4422(05)70194-0.View ArticlePubMed
- Vargas JD, et al: Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases. Biochim Biophys Acta. 2003, 1651 (1–2): 116-123.View ArticlePubMed
- Genzen JR, et al: Activation of adenosine A2B receptors enhances ciliary beat frequency in mouse lateral ventricle ependymal cells. Cerebrospinal Fluid Res. 2009, 6: 15-10.1186/1743-8454-6-15.PubMed CentralView ArticlePubMed
- Morishita Y, et al: Disruption of aquaporin-11 produces polycystic kidneys following vacuolization of the proximal tubule. Mol Cell Biol. 2005, 25 (17): 7770-7779. 10.1128/MCB.25.17.7770-7779.2005.PubMed CentralView ArticlePubMed
- Liu RZ, et al: Fatty acid binding proteins in brain development and disease. Int J Dev Biol. 2010, 54 (8–9): 1229-1239.View ArticlePubMed
- Dreuw A, et al: Interleukin-6-type cytokines upregulate expression of multidrug resistance-associated proteins in NHEK and dermal fibroblasts. J Invest Dermatol. 2005, 124 (1): 28-37. 10.1111/j.0022-202X.2004.23499.x.View ArticlePubMed
- Obregon-Henao A, et al: The role of N-linked carbohydrates in the antigenicity of Taenia solium metacestode glycoproteins of 12, 16 and 18 kD. Mol Biochem Parasitol. 2001, 114 (2): 209-215. 10.1016/S0166-6851(01)00256-0.View ArticlePubMed
- Restrepo BI, et al: Analysis of the peripheral immune response in patients with neurocysticercosis: evidence for T cell reactivity to parasite glycoprotein and vesicular fluid antigens. Am J Trop Med Hyg. 2001, 65 (4): 366-370.PubMed
- Lopez-Marin LM, et al: Structure and antigenicity of the major glycolipid from Taenia solium cysticerci. Mol Biochem Parasitol. 2002, 119 (1): 33-42. 10.1016/S0166-6851(01)00396-6.View ArticlePubMed
- Obregon-Henao A, et al: In situ detection of antigenic glycoproteins in Taenia solium metacestodes. J Parasitol. 2003, 89 (4): 726-732. 10.1645/GE-3046.View ArticlePubMed
- Alvarez JI, Rivera J, Teale JM: Differential release and phagocytosis of tegument glycoconjugates in neurocysticercosis: implications for immune evasion strategies. PLoS Negl Trop Dis. 2008, 2 (4): e218-10.1371/journal.pntd.0000218.PubMed CentralView ArticlePubMed
- Estes DM, Teale JM: Biochemical and functional analysis of extracellular stress proteins of Mesocestoides corti. J Immunol. 1991, 147 (11): 3926-3934.PubMed
- Fleury A, et al: Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Trans R Soc Trop Med Hyg. 2010, 104 (4): 243-250. 10.1016/j.trstmh.2010.01.005.View ArticlePubMed
- Mabey DC, et al: Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease. J Clin Pathol. 1991, 44 (4): 285-289. 10.1136/jcp.44.4.285.PubMed CentralView ArticlePubMed
- Alldinger S, et al: Up-regulation of major histocompatibility complex class II antigen expression in the central nervous system of dogs with spontaneous canine distemper virus encephalitis. Acta Neuropathol. 1996, 92 (3): 273-280. 10.1007/s004010050518.View ArticlePubMed
- Engelhardt B, Wolburg-Buchholz K, Wolburg H: Involvement of the choroid plexus in central nervous system inflammation. Microsc Res Tech. 2001, 52 (1): 112-129. 10.1002/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5.View ArticlePubMed
- Flugel A, et al: Autoaggressive effector T cells in the course of experimental autoimmune encephalomyelitis visualized in the light of two-photon microscopy. J Neuroimmunol. 2007, 191 (1–2): 86-97.View ArticlePubMed
- Uetani K, et al: Influenza A virus abrogates IFN-gamma response in respiratory epithelial cells by disruption of the Jak/Stat pathway. Eur J Immunol. 2008, 38 (6): 1559-1573. 10.1002/eji.200737045.View ArticlePubMed
- Reith W, LeibundGut-Landmann S, Waldburger JM: Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol. 2005, 5 (10): 793-806. 10.1038/nri1708.View ArticlePubMed
- Birmachu W, et al: Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists. BMC Immunol. 2007, 8: 26-10.1186/1471-2172-8-26.PubMed CentralView ArticlePubMed
- Steiniger B, van der Meide PH: Rat ependyma and microglia cells express class II MHC antigens after intravenous infusion of recombinant gamma interferon. J Neuroimmunol. 1988, 19 (1–2): 111-118.View ArticlePubMed
- Nonaka M, et al: GM-CSF, IL-8, IL-1R, TNF-alpha R, and HLA-DR in nasal epithelial cells in allergic rhinitis. Am J Respir Crit Care Med. 1996, 153 (5): 1675-1681.View ArticlePubMed
- Aubert V, et al: Induction of tumor necrosis factor alpha and interleukin-8 gene expression in bronchial epithelial cells by toxic shock syndrome toxin 1. Infect Immun. 2000, 68 (1): 120-124. 10.1128/IAI.68.1.120-124.2000.PubMed CentralView ArticlePubMed
- Kalb TH, et al: Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am J Respir Cell Mol Biol. 1991, 4 (4): 320-329.View ArticlePubMed
- Rossi GA, et al: Human ciliated bronchial epithelial cells: expression of the HLA-DR antigens and of the HLA-DR alpha gene, modulation of the HLA-DR antigens by gamma-interferon and antigen-presenting function in the mixed leukocyte reaction. Am J Respir Cell Mol Biol. 1990, 3 (5): 431-439.View ArticlePubMed
- Siebert H, et al: The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J Neuroimmunol. 2000, 110 (1–2): 177-185.View ArticlePubMed
- Ransohoff RM: Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity. 2009, 31 (5): 711-721. 10.1016/j.immuni.2009.09.010.PubMed CentralView ArticlePubMed
- Rebenko-Moll NM, et al: Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr Opin Immunol. 2006, 18 (6): 683-689. 10.1016/j.coi.2006.09.005.View ArticlePubMed
- Viola A, Luster AD: Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol. 2008, 48: 171-197. 10.1146/annurev.pharmtox.48.121806.154841.View ArticlePubMed
- Stiles LN, et al: Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS. Eur J Immunol. 2006, 36 (3): 613-622. 10.1002/eji.200535509.View ArticlePubMed
- Cuetter AC, et al: Neurocysticercosis: focus on intraventricular disease. Clin Infect Dis. 1997, 24 (2): 157-164. 10.1093/clinids/24.2.157.View ArticlePubMed
- Cuetter AC, Andrews RJ: Intraventricular neurocysticercosis: 18 consecutive patients and review of the literature. Neurosurg Focus. 2002, 12 (6): e5.View ArticlePubMed
- Garcia HH, et al: New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg. 2005, 72 (1): 3-9.PubMed
- Cardenas G, et al: Subarachnoidal neurocysticercosis non-responsive to cysticidal drugs: a case series. BMC Neurol. 2010, 10: 16-10.1186/1471-2377-10-16.PubMed CentralView ArticlePubMed
- Fleury A, et al: Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther. 2011, 9 (1): 123-133. 10.1586/eri.10.150.View ArticlePubMed
- Couldwell WT: Intraventricular neurocysticercosis. J Neurosurg. 2003, 98 (3): 648-author reply 648–9.PubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.